Aemetis Reports Second Quarter 2026 Financial Results

Aemetis reported Q2 2026 revenue of $62.7M (+$10.5M, +20% YoY) and flipped to operating income of $5.8M (from an operating loss of $10.7M). Adjusted EBITDA rose to $9.7M (from negative $5.8M), with Section 45Z production tax credits totaling $8.6M in the quarter and Dairy RNG sales volume up 38% to 146,900 MMBtu. Despite improving profitability, cash declined to $1.0M and the company is pursuing multi-track financing for near-term obligations as the Keyes MVR project is expected to become operational in 2026.

Analysis

This is a classic “good quarter, bad capital structure” setup. The operating inflection matters less for equity value than the company’s ability to turn tax-credit economics into bankable, refinanceable cash before the balance sheet forces dilution; in that sense the quarter de-risks the model but not the stock. The market should treat the earnings power as a floor, not as proof that common equity is out of the woods.

Second-order, the winners are the counterparties that get paid in real assets and fees: project contractors, equipment vendors, and feedstock partners benefit from continued digester buildout, but the delay in commissioning pushes the cash-payback curve further right. That also creates a competitive opening for better-capitalized RNG and renewable fuels peers to lock in scarce dairy/LCFS-linked deals on more favorable terms while this name is still negotiating from a stressed balance sheet.

The key near-term catalyst is financing, not production. Over the next 1-3 months, any silence on refinancing or a vague equity solution will likely cap upside; over 6-18 months, the story only works if lower-carbon fuel credits and plant efficiency convert into sustainable free cash flow after capex and interest. The contrarian risk is that investors may be capitalizing tax-credit revenue as if it were recurring cash generation; a dip in LCFS pricing, slower 45Z monetization, or a funding setback would quickly unwind that optimism.

Key Decisions for Investors

• Short AMTX on post-earnings strength; this is a financing-overhang trade, not an operating-quality long. Use a 4-8 week horizon and keep a tight stop if management announces a credible, non-dilutive refinance.
• If implied volatility is still reasonable, buy 2-3 month AMTX put spreads to express the dilution/refinancing risk with defined downside. Falsify the trade if the company secures long-term debt at materially better terms than expected.
• Do not chase the headline EBITDA improvement into the print; wait for the next filing or call for explicit detail on liquidity runway and refinancing. This is the cleaner risk-controlled entry point than buying a quarter with accounting support and weak cash.
• Relative-value alert: pair long a stronger, better-capitalized renewable fuels/bioenergy platform versus short AMTX if the market keeps rewarding tax-credit optics over balance-sheet quality. The spread should widen if financing terms remain unresolved over the next 1-3 months.
• Set a watch item on LCFS and 45Z monetization assumptions: any step-down in credit pricing or policy timing would be the quickest way to invalidate the bull case and likely pressure the stock first.